Jean-francois F. Timsit
Expertise in
20
conditions

Jean-francois F. Timsit

Paris, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
20
conditions
Paris, FR 

Overview

Jean-francois Timsit practices in Paris, France. Mr. Timsit is highly rated in 20 conditions, according to our data. His top areas of expertise are Pneumonia, Hospital-Acquired Pneumonia, Sepsis, COVID-19, and Lung Transplant.

His clinical research consists of co-authoring 554 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Paris, France
Other Locations
Drancy, 93000, France
Limoges, France
Angers, France
Creteil, France
La Tronche, France
Saint-claude-de-diray, France
Clermont-ferrand, France
OUTCOMEREA™
Bobigny, France
Grenoble, France
Aulnay-sur-mauldre, France
Besancon, France
Clichy-sous-bois, 92110, France
Albert, 38000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

New Predictive Tool of Awakening in Comatose Patients in the Intensive Care Unit
New Predictive Tool of Awakening in Comatose Patients in the Intensive Care Unit
Enrollment Status: Recruiting
Publish Date: December 23, 2025
Intervention Type: Other
Impact of a Strategy Combining the Rapid Polymerase Chain Reaction Platform FilmArray® and the Intervention of an Antimicrobial Stewardship Team in Hospital-acquired Pneumonia : a Randomized Controlled Trial.
Impact of a Strategy Combining the Rapid Polymerase Chain Reaction Platform FilmArray® and the Intervention of an Antimicrobial Stewardship Team in Hospital-acquired Pneumonia : a Randomized Controlled Trial.
Enrollment Status: Completed
Publish Date: November 20, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Other, Drug
Study Drugs: Remdesivir, Lopinavir, Ritonavir, Interferon Beta-1A, Hydroxychloroquine, AZD7442
Study Phase: Phase 3
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care: the Eurobact II Multinational Cohort Study
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care: the Eurobact II Multinational Cohort Study
Enrollment Status: Completed
Publish Date: September 09, 2021
Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)
Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO)
Enrollment Status: Completed
Publish Date: May 07, 2021
Intervention Type: Other
Study Phase: Not Applicable
Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU
Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU
Enrollment Status: Completed
Publish Date: March 30, 2021
View 5 Less Clinical Trials

554 Total Publications

Long-Term Functional and Quality-of-Life Outcomes in Survivors of Refractory Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation.
Long-Term Functional and Quality-of-Life Outcomes in Survivors of Refractory Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation.
Journal: Critical care explorations
Published: December 02, 2025

Frequently Asked Questions about Jean-francois F. Timsit

Is Jean-francois F. Timsit a top-rated expert for Pneumonia?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-francois F. Timsit is classified as an Elite expert for Pneumonia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-francois F. Timsit participate in research or clinical trials?

Yes. Jean-francois F. Timsit has published 554 articles and abstracts on conditions like Pneumonia. You can view a list of Jean-francois F. Timsit's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Timsit's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 52 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile